Bone scan as a stratification variable in advanced prostate cancer.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 2070330.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The serial technetium 99 (99Tc) bone scans of 76 patients with Stage D-2 prostate cancers were reviewed. Sites of metastases in skeletal areas in decreasing order were vertebrae, ribs, pelvis, long bones, and skull. Patients with one or two involved skeletal areas had a significantly longer progression-free interval and survival time than patients with three or more bony areas of uptake. Bone scans might be used as a stratification variable in future prospective clinical trials of Stage D-2 prostate cancer.
Medical subject headings
- Bone Neoplasms
- Prostatic Neoplasms
- Technetium Tc 99m Medronate